Asset
VK-0214
Viking Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04973657 | phase1 | completed | 2021-06-22 | 2024-10-09 | Viking Therapeutics, Inc. | A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN |
FDA applications (0)
This company has no applications containing this asset.